Original Research Online Published: 14 Sep 2021 | ||||||||||||
Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity Rajiv Jash, Chiranjib Bagchi, Achintya Mitra, Santanu Kumar Tripathi.
|
How to Cite this Article |
Pubmed Style Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. Natl J Physiol Pharm Pharmacol. 2022; 12(3): 289-295. doi:10.5455/njppp.2022.12.08304202101092021 Web Style Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. https://www.njppp.com/?mno=114616 [Access: February 06, 2025]. doi:10.5455/njppp.2022.12.08304202101092021 AMA (American Medical Association) Style Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. Natl J Physiol Pharm Pharmacol. 2022; 12(3): 289-295. doi:10.5455/njppp.2022.12.08304202101092021 Vancouver/ICMJE Style Jash R, Bagchi C, Mitra A, Tripathi SK. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. Natl J Physiol Pharm Pharmacol. (2022), [cited February 06, 2025]; 12(3): 289-295. doi:10.5455/njppp.2022.12.08304202101092021 Harvard Style Jash, R., Bagchi, . C., Mitra, . A. & Tripathi, . S. K. (2022) Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. Natl J Physiol Pharm Pharmacol, 12 (3), 289-295. doi:10.5455/njppp.2022.12.08304202101092021 Turabian Style Jash, Rajiv, Chiranjib Bagchi, Achintya Mitra, and Santanu Kumar Tripathi. 2022. Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. National Journal of Physiology, Pharmacy and Pharmacology, 12 (3), 289-295. doi:10.5455/njppp.2022.12.08304202101092021 Chicago Style Jash, Rajiv, Chiranjib Bagchi, Achintya Mitra, and Santanu Kumar Tripathi. "Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 289-295. doi:10.5455/njppp.2022.12.08304202101092021 MLA (The Modern Language Association) Style Jash, Rajiv, Chiranjib Bagchi, Achintya Mitra, and Santanu Kumar Tripathi. "Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity." National Journal of Physiology, Pharmacy and Pharmacology 12.3 (2022), 289-295. Print. doi:10.5455/njppp.2022.12.08304202101092021 APA (American Psychological Association) Style Jash, R., Bagchi, . C., Mitra, . A. & Tripathi, . S. K. (2022) Evaluation of antihyperlipidemic activity of gugulipid alone and in combination with different dosage of atorvastatin in triton-induced hyperlipidemic rodent model: Exploring a possible synergistic activity. National Journal of Physiology, Pharmacy and Pharmacology, 12 (3), 289-295. doi:10.5455/njppp.2022.12.08304202101092021 |